BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kak M. Rebamipide in gastric mucosal protection and healing: An Asian perspective. World J Gastrointest Pharmacol Ther 2025; 16(1): 101753 [PMID: 40094150 DOI: 10.4292/wjgpt.v16.i1.101753]
URL: https://www.wjgnet.com/2150-5349/full/v16/i1/101753.htm
Number Citing Articles
1
Akanksha Mishra, Sairam Krishnamurthy. Design, characterization and evaluation of a novel dosage form of rebamipide as transdermal patches in rodent model of Parkinson’s diseaseProspects in Pharmaceutical Sciences 2026;  doi: 10.56782/pps.650
2
Igor V. Maev, Alsu R. Khurmatullina, Dmitrii N. Andreev, Andrew V. Zaborovsky, Yury A. Kucheryavyy, Philipp S. Sokolov, Petr A. Beliy. Rebamipide as an Adjunctive Therapy for Gastrointestinal Diseases: An Umbrella ReviewPharmaceuticals 2026; 19(1): 144 doi: 10.3390/ph19010144
3
Chenyu Zou, Yu Cao, Juxiong Liu, Xian Dong, Junlong Bi, Wenjin Guo, Shoupeng Fu. Confronting bacterial mastitis: From pathogen diversity to sustainable control in the post-antibiotic eraAnimals and Zoonoses 2026; 2(1): 48 doi: 10.1016/j.azn.2025.07.004
4
Nagla A. El-Shitany, Nageh Ahmed El-Mahdy, Ola Mahmoud Waly, Aya Hassan El-Kadem. Rebamipide modulates the miR-29a/SIRT1/FoxO3a and NF-κB pathways in methotrexate-induced testicular damageEuropean Journal of Pharmacology 2025; 1005: 178063 doi: 10.1016/j.ejphar.2025.178063
5
Jaewon Park, Kyoung Yul Seo, Hyunmin Ahn, Yearim Shin, Ikhyun Jun, Tae-im Kim, Bum Kyu Shin, Da-Young Yoon, Soo-Min Lee. Efficacy and Safety of SA001 in Patients with Primary Sjögren’s Syndrome: A Randomized, Double-Blind, Placebo-Controlled TrialPharmaceuticals 2026; 19(1): 189 doi: 10.3390/ph19010189
6
Hyejoo Lee, Na Rae Lim, Seonwoo Kim, Hyun Cho, Woo Chul Chung. Comparative Efficacy and Safety of Stillen® and Rebamipide in Patients with Acute or Chronic Gastritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Medicine 2025; 14(17): 6209 doi: 10.3390/jcm14176209